Tandutinib
Tandutinib (MLN518) is a potent and selective inhibitor of the FLT3 with an IC50 of 0.22 μM, and also inhibits c-Kit and PDGFR with IC50s of 0.17 μM and 0.20 μM, respectively. Tandutinib can be used for acute myelogenous leukemia (AML) [1][2]. Tandutinib has the ability to cross the blood-brain barrier[3].
Product Specifications
CAS Number
387867-13-2
Product Name Alternative
MLN518; CT53518
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; c-Kit; FLT3; PDGFR
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Tandutinib.html
Purity
99.48
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N1CCN(C2=C(C(C=C3OCCCN4CCCCC4)=NC=N2)C=C3OC)CC1)NC5=CC=C(OC(C)C)C=C5
Molecular Formula
C31H42N6O4
Molecular Weight
562.70
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
PDGFR
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Thyroglobulin (TGB04 + TGB05), CF647 conjugate, 0.1mg/mL
HPV16 E2 (Human Papilloma Virus 16) (TVG 261), 0.2mg/mL
HRPT2 (CDC73) (NM_024529) Human Over-expression Lysate
